Deborah L. Feinstein, Director, manages the Bureau’s nearly 300 employees. Debbie was appointed Director in July 2013, coming to the Commission from private practice. She previously served as an Assistant to former Bureau Director Kevin Arquit and as an Attorney Advisor to former Commissioner Dennis Yao. She is a graduate of Harvard Law School.
Norman Armstrong, Jr., Deputy Director, oversees the Mergers II, Mergers III, and Mergers IV Divisions, as well as competition matters staffed by the Western Region and the Northwest Region. Norm came to the Commission in 1995 after graduating from Howard University School of Law, spent several years on the staff of the Mergers I Division, and served as the Deputy Assistant Director for Mergers IV.
Marian Bruno, Deputy Director, oversees the Bureau’s Premerger Notification Office, Compliance Division, Office of Policy and Coordination, Operations Division, Honors Paralegal Program, and Technology and Management Division. Marian was named Deputy Director in 2008, having previously served as an Associate Director, Assistant Director, and Senior Assistant to the Bureau Director. She joined the Commission in 1990 from private practice and holds a JD from the University of Arkansas.
Stephen Weissman, Deputy Director, oversees Mergers I, Anticompetitive Practices, the Health Care Division, and competition matters in the Northeast Region. Steve came to the FTC in 2013 from private practice and received his JD from the University of Pennsylvania.
The Director’s Office is also home to the Bureau’s Litigation Group. Edward Hassi, Chief Trial Counsel, leads a team of experienced litigators and litigation support professionals who provide training, support, and oversight of the Bureau’s litigation docket. Michael Kades serves as the Deputy Chief Trial Counsel. Other members of the Litigation Group include Thomas Brock, J. Thomas Greene, Peter Herrick, Henry Su, Teresa Martin, and Devon Kelly.
PREMERGER NOTIFICATION OFFICE (PNO)
Robert Jones, Assistant Director Kate Walsh, Deputy Assistant Director
The Premerger Notification Office administers the HSR program for both the FTC and the DOJ. Experts in HSR law and practice, PNO staff conduct the initial review of transactions subject to the HSR Act, and if the filings raise a competitive issue, coordinate the clearance process between the FTC and the DOJ. PNO staff respond to thousands of calls each year about premerger filing requirements, and can be easily accessed by calling the main PNO office number, 202-326-3100. Visit the PNO pages on the website for more HSR information and advice.
OFFICE OF POLICY & COORDINATION (OPC)
Michael Bloom, Assistant Director James Mongoven, Deputy Assistant Director
OPC works with Bureau and Commission staff on litigation matters, speeches, testimony, appellate briefs, advisory opinions, and briefing papers. OPC attorneys also answer general antitrust inquiries received through email@example.com or the BC Phone Line at (202) 326-3300.
Michael Moiseyev, Assistant Director James Weiss and Daniel Zach, Deputy Assistant Directors
The Division’s primary area of responsibility is reviewing transactions in health care-related industries, included branded and generic pharmaceutical manufacturing and distribution, medical devices, and consumer health products. The Division also handles matters involving defense, scientific, industrial, technology, and consumer products. Mergers I has also been active in technology markets recently, such as those involving online search engines (Google/AdMob) and audience measurement services (Nielsen/Arbirtron).
Catharine Moscatelli, Assistant Director Benjamin Gris and James Rhilinger, Deputy Assistant Directors
The Mergers II Division oversees a wide variety of industries including coal mines, chemicals, entertainment, and computer hardware and software. The Division has successfully challenged mergers in both federal and administrative courts, including CCC/Mitchell (auto insurance software) and Polypore (battery separators).
Phillip Broyles, Assistant Director Peter Richman and Patricia Galvan, Deputy Assistant Directors
The Mergers III Division is home to many of the FTC’s experts on the oil and gas industries, including pipelines, terminals and retailing. In recent years, Mergers III has also reviewed mergers in other industries, including equipment used in the industrial spray coatings industry, and title plants. Mergers III also helps prepare the FTC’s annual report on concentration in the ethanol industry, and enforces the Commission’s rule preventing market manipulation in wholesale petroleum markets. See the Oil & Gas pages for additional information on the FTC’s oil and gas initiatives.
Alexis Gilman, Assistant Director Kevin Hahm and Mark Seidman, Deputy Assistant Directors
The Mergers IV Division investigates transactions involving hospitals, consumer goods, supermarkets, funeral homes, retail outlets, multichannel video programming distribution, and media. The Division recently litigated a number of cases in federal court and before the ALJ, including Promedica’s acquisition of St. Luke’s Hospital in the Toledo area and the OSF/Rockford hospital merger.
HEALTH CARE DIVISION
Markus Meier, Assistant Director Bradley Albert and Saralisa Brau, Deputy Assistant Directors
The Health Care Division investigates the business activities of physicians and other health professionals, pharmaceutical companies, institutional providers, and insurers, and also reviews mergers involving health care products and services. The Division’s early work led to several landmark cases in the Supreme Court and lower federal courts applying antitrust law principals to conduct by physicians, hospitals, and other health care providers. Today, a major focus of the Health Care Division is the FTC’s effort to stop anticompetitive pay-for-delay agreements among pharmaceutical companies that unlawfully insulate branded drugs from competition from lower-cost generic drugs. The Division also provides guidance on health care competition to policy makers, federal and foreign agencies, industry, and the public; much of this guidance is available on the Health Care webpages.
ANTICOMPETITIVE PRACTICES (ACP)
Geoffrey Green, Assistant Director Barbara Blank and Mark Woodward, Deputy Assistant Directors
ACP is the center of the Bureau’s enforcement efforts against anticompetitive conduct in industries other than health care and pharmaceuticals. ACP’s work involves not only stopping illegal conduct but also shaping the law. ACP’s ongoing work includes issues of intellectual property rights, attempts by professional and regulatory boards to limit competition, and immunities from and exceptions to the antitrust laws. In the area of industry standard-setting, ACP has become well-known for a series of cases involving anticompetitive conduct by members of standard-setting organizations.
Daniel Ducore, Assistant Director Roberta Baruch and Elizabeth Piotrowski, Deputy Assistant Directors
The Compliance Division staff help draft and negotiate Commission orders originating in the Bureau, and oversee company conduct required by the order. Compliance staff review proposed divestitures, and go to court to enforce Commission orders and to seek penalties for order violations. The Division also evaluates requests to reopen, modify, or set aside orders, and renders advice to respondents regarding their order obligations, and investigates possible violations of the HSR Act and recommends enforcement actions when violations are found.
Three regional offices also handle competition investigations: